sg001

mAbexperimental

Clinical trial activity

14 trials · 7 clinical orgs · 0 marketing orgs

Phase 1
5
Phase 2
12
Phase 3
2
Phase 4
0

Earliest trial started Mar 28, 2019 (NCT03852823)

Timeline

2010s

  1. Jan 1, 2019

    Earliest Phase 1 Sponsor(trial)

2020s

  1. Jan 1, 2021

    Earliest Phase 2 Sponsor(trial)

  2. Jan 1, 2023

    Earliest Phase 3 Sponsor(trial)

Indications

Mechanism of action

Chemistry & pharmacology

Multi-specific
No

Oral

No

Parenteral

No

Topical

No

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT07251062Phase 2/Phase 3 (Phase 3)Dec 30, 2025Shijiazhuang Pharma Group (CSPC)
NCT06989671Phase 2Aug 30, 2025Shijiazhuang Pharma Group (CSPC)
NCT07183865Phase 2Mar 9, 2025Fudan University
NCT06682611Phase 1/Phase 2 (Phase 2)Nov 13, 2024
NCT06089330Phase 2Jan 31, 2024Shanghai JMT-Bio Inc.
NCT06132217Phase 1/Phase 2 (Phase 2)Jan 30, 2024
NCT06136988Phase 1/Phase 2 (Phase 2)Dec 31, 2023Shijiazhuang Pharma Group (CSPC)
NCT05715840Phase 3Jan 31, 2023Shijiazhuang Pharma Group (CSPC), Tsinghua University
NCT05508659Phase 1/Phase 2 (Phase 2)Sep 20, 2022Shijiazhuang Pharma Group (CSPC)
NCT05068141Phase 2Oct 1, 2021Shijiazhuang Pharma Group (CSPC), Sun Yat-Sen University
NCT05009953Phase 2Sep 30, 2021Chinese Academy of Medical Sciences, Yiling Pharmaceutical Inc.
NCT04983550Phase 2Sep 30, 2021Shijiazhuang Pharma Group (CSPC)
NCT04886700Phase 2Jul 31, 2021Chinese Academy of Medical Sciences, Shijiazhuang Pharma Group (CSPC)
NCT03852823Phase 1Mar 28, 2019Shijiazhuang Pharma Group (CSPC)
Showing 14 of 14 trials
Page 1 / 1

Organizations

Research & Development (7)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Shijiazhuang Pharma Group (CSPC)For profit9932019
Chinese Academy of Medical SciencesAcademic/Hospital2012021
Fudan UniversityAcademic/Hospital1112025
Shanghai JMT-Bio Inc.For profit1112024
Sun Yat-Sen UniversityAcademic/Hospital1012021
Tsinghua UniversityAcademic/Hospital1012023
Yiling Pharmaceutical Inc.For profit1112021
7 organizations
Page 1 / 1